Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bonhams 1793 Limited in connection with its acquisition of Bukowski
Mandate

Vinge advises Bonhams 1793 Limited in connection with its acquisition of Bukowski

January 11, 2022 M&A

Vinge has advised Bonhams 1793 Limited, an international auction house with its head office in London, and a portfolio company of Epiris LLP, in connection with its acquisition of Bukowski Auktioner Aktiebolag (”Bukowski”).

Bukowski is an auction house within art and antiquities with its head office in Berzelii Park in Stockholm. The company also has a Finnish Subsidiary, Bukowski Oy. Through the acquisition, Bonhams will extend its geographical presence in Europe.

Vinge’s team consisted of, among others, Christina Kokko, Isabelle Wållgren, Hannah Kajlinger, Christa Anttila, Vilhelm Rondahl and Ellen Åkerdahl Flygt (M&A), Anton Sjökvist and Caroline Krassén (Financial Services), Tove Lövgren Frisk (Compliance), Karl-Hugo Engdahl (GDPR, IT), Ulf Pyk (Real Estate), Karolina Fuhrman and Isabell Nielsen (Corporate Commercial), Arvid Axelryd (IP), Emil Lindvall and Gustav Lindgren (Employment) as well as Sara Dahlros Sköld (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025